PMS48 Intravenously Administered Golimumab Significantly Improves Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis: Results of a Phase III, Placebo-Controlled Trial

R Westhovens,M.E Weinblatt,C Han,T Gathany,L Kim,M Mack,J Lu,D Baker,A Mendelsohn,C Bingham

doi:10.1016/j.jval.2012.03.237

PMS48 Intravenously Administered Golimumab Significantly Improves Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis: Results of a Phase III, Placebo-Controlled Trial

R Westhovens, M.E Weinblatt + Show 8 more

Open Access

https://doi.org/10.1016/j.jval.2012.03.237

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: May 23, 2012
License type: publisher-specific-oa

Affiliation: Universitair Ziekenhuis Leuven, Johnson & Johnson (United States), Janssen (United States), Ortho Clinical Diagnostics (United States), Johns Hopkins University

#Work Productivity In Patients #Work Productivity + Show 5 more

Abstract
Full-Text PDF
Similar Papers

Abstract

PMS48 Intravenously Administered Golimumab Significantly Improves Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis: Results of a Phase III, Placebo-Controlled Trial

Full Text